Valuation: Clover Corporation Limited

Market Cap 136M 94.41M 82.49M 75.75M 70.64M 134M 8.99B 912M 353M 4.41B 354M 347M 15.19B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 136M 94.41M 82.49M 75.75M 70.64M 134M 8.99B 912M 353M 4.41B 354M 347M 15.19B EV / Sales 2026 *
1.52x
EV / Sales 2027 * 1.43x
Free-Float
81.15%
Yield 2026 *
2.2%
Yield 2027 * 2.93%
1 day-9.15%
1 week-13.37%
Current month-11.83%
1 month-21.16%
3 months-31.34%
6 months-6.29%
Current year-5.70%
1 week 0.74
Extreme 0.745
0.86
1 month 0.74
Extreme 0.745
0.97
Current year 0.7
Extreme 0.7
1.16
1 year 0.52
Extreme 0.515
1.16
3 years 0.34
Extreme 0.337
1.22
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 2014-11-10
Director of Finance/CFO - 2021-05-05
Chief Operating Officer - 2011-02-02
Director TitleAgeSince
Director/Board Member - 2014-11-10
Chairman - 2017-09-20
Director/Board Member - 2017-01-31
Date Insider Type Main position Quantity % Market Cap.
11-17Sell

Chief Executive Officer

255,199 0.1528%
11-17Buy

Chief Executive Officer

529,638 0.3171%
11-05Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-9.15%-13.37%+40.57%-39.18% 94.41M
+0.80%+0.73%+41.28%+96.23% 13.66B
+12.16%+31.99%-33.29%+221.09% 7.07B
+1.19%-4.21%-17.60%-61.13% 2.3B
+3.82%+21.69%-75.90%-62.13% 1.61B
-3.85%-20.38% - - 1.44B
+0.92%+9.52%+34.74%-0.98% 1.36B
+1.07%+3.96%-30.21%-24.64% 1.27B
+1.70%+11.72%-57.15%-62.48% 1.24B
+0.29%+4.03%+19.05%+39.29% 1.22B
Average +0.90%+6.76%-8.72%+11.78% 3.13B
Weighted average by Cap. +3.34%+10.65%+4.38%+86.19%

Financials

2026 *2027 *
Net sales 89.4M 61.98M 54.15M 49.73M 46.38M 87.92M 5.9B 599M 232M 2.89B 233M 228M 9.97B 95.3M 66.07M 57.73M 53.01M 49.44M 93.72M 6.29B 638M 247M 3.08B 248M 243M 10.63B
Net income - -
Net Debt - -
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
26-07-03 A$0.7450 -9.15% 439,842
26-07-02 A$0.8200 0.00% 25,022
26-07-01 A$0.8200 -2.96% 28,049
26-06-30 A$0.8450 -0.59% 68,497
26-06-29 A$0.8500 -1.16% 78,736
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8200AUD
Average target price
0.8700AUD
Spread / Average Target
+6.10%

Annual profits - Rate of surprise